Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Can HIV-1-specific ADCC assist...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells?

Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells?

Bibliographic Details
Main Authors: Wen Shi eLee, Matthew Sidney Parsons, Stephen John Kent, Marit eLichtfuss
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Immunology
Subjects:
HIV
antibody
latency
NK cell
HIV cure
Antibody-dependent cellular cytotoxicity (ADCC)
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00265/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00265/full

Similar Items

  • Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
    by: Poonam Suryawanshi, et al.
    Published: (2021-04-01)
  • Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts
    by: Zak A. Yaffe, et al.
    Published: (2021-04-01)
  • A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
    by: Emilie Decaup, et al.
    Published: (2019-08-01)
  • ADCC against MICA/B is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
    by: Kawaljit Kaur, et al.
    Published: (2021-01-01)
  • NK cell-based autologous immune enhancement therapy (AIET) for cancer (Invited Review)
    by: Terunuma H, et al.
    Published: (2013-04-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...